Evidence map›Paper›PMID 29876284›Full record

ArticleNeuroImage. Clinical2018

The site of stimulation moderates neuropsychiatric symptoms after subthalamic deep brain stimulation for Parkinson's disease.

Philip E Mosley, David Smith, Terry Coyne, Peter Silburn, Michael Breakspear, Alistair Perry

Registry-linked trialAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05444907 (Understanding Deep Brain Stimulation-induced Mania), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05444907 recruitingnot on this mapstarted 2021, after this paper: background citation

Understanding Deep Brain Stimulation-induced Mania: Finding Potential Predictors to Optimize Treatment

TypeobservationalSponsorAlbino MaiaRan2021 to 2025Enrolled100ConditionsMania, Parkinson DiseaseArmsNo Intervention / Exposure
3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Functional neuroanatomy of mania.Translational psychiatry · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philip E MosleySystems Neuroscience Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Neurosciences Queensland, St Andrew's War Memorial Hospital, Spring Hill, Queensland, Australia; Queensland Brain Institute, University of Queensland, St Lucia, Queensland, Australia; Faculty of Medicine, University of Queensland, Herston, Queensland, Australia. Electronic address: philip.mosley@qimrberghofer.edu.au.
David SmithSystems Neuroscience Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Terry CoyneQueensland Brain Institute, University of Queensland, St Lucia, Queensland, Australia; Brizbrain and Spine, The Wesley Hospital, Auchenflower, Queensland, Australia.
Peter SilburnNeurosciences Queensland, St Andrew's War Memorial Hospital, Spring Hill, Queensland, Australia; Queensland Brain Institute, University of Queensland, St Lucia, Queensland, Australia.
Michael BreakspearSystems Neuroscience Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Alistair PerrySystems Neuroscience Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Max Planck UCL Centre for Computational Psychiatry and Ageing Research, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep brain stimulation of the subthalamic nucleus for Parkinson's disease is an established advanced therapy that addresses motor symptoms and improves quality of life. However, it has also been associated with neuropsychiatric symptoms such as impulsivity and hypomania. When significant, these symptoms can be distressing, necessitating psychiatric intervention. However, a comprehensive analysis of neurocognitive and neuropsychiatric outcomes with reference to the site of subthalamic stimulation has not been undertaken. We examined this matter in a consecutive sample of 64 persons with Parkinson's disease undertaking subthalamic deep brain stimulation. Participants were assessed with a battery of neuropsychiatric instruments at baseline and at repeated postoperative intervals. A psychiatrist identified patients with emergent, clinically-significant symptoms due to stimulation. The site of the active electrode contact and a simulated volume of activated tissue were evaluated with reference to putative limbic, associative and motor subregions of the subthalamic nucleus. We studied anatomical correlates of longitudinal neuropsychiatric change and delineated specific subthalamic regions associated with neuropsychiatric impairment. We tested the ability of these data to predict clinically-significant symptoms. Subthalamic stimulation within the right associative subregion was associated with inhibitory errors on the Excluded Letter Fluency task at 6-weeks (

Indexed as

Deep Brain StimulationAdultAgedFemaleHumansImpulsive BehaviorMaleMental DisordersMiddle AgedNeuropsychological TestsParkinson DiseaseQuality of LifeSubthalamic NucleusTreatment OutcomeDeep brain stimulationImpulsivityNeuropsychiatryParkinson's diseaseSubthalamic nucleus

Identifiers

PMID29876284
PMCPMC5988013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.